| 3-MA | 3-methyladenine |
| 5-FU | 5-fluorouracil |
| ABCB1 | ATP binding cassette subfamily B member1 |
| ACAC | acetyl-CoA carboxylase |
| ACD | autophagic cell death |
| AIFM | apoptosis-inducing factor mitochondria associated |
| AKT/Protein kinase B | AKT serine/threonine kinase |
| AMP | adenosine monophosphate |
| AMPK | 5′-AMP-activated protein kinase |
| AP-1 | activator protein 1 |
| AR | androgen receptor |
| ATF | activating transcription factor |
| ATG | autophagy related |
| ATG16L1 | autophagy-related 16 like 1 |
| ATP | adenosine triphosphate |
| ATP2A1 | ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
| AVOs | acidic vesicular organelles |
| BAD | BCL2 associated agonist of cell death |
| BAX | BCL2 associated X, apoptosis regulator |
| BBC3/PUMA | BCL2 binding component 3/p53 upregulated modulator of apoptosis |
| BCL2 | B-cell lymphoma 2 |
| BDMC | bisdemethoxycurcumin |
| BID | BH3 interacting domain death agonist |
| BIRC5 | baculoviral IAP repeat containing 5 |
| BNIP3 | BCL2 interacting protein 3 |
| BRAFi | potent inhibitors of v-Raf murine sarcoma viral oncogene homolog B |
| CALR | calreticulin |
| CAPN2 | calpain 2 |
| CASP3 | caspase 3 |
| CCNA | cyclin A |
| CCNB | cyclin B |
| CCND | cyclin D |
| CCNE | cyclin E |
| CDK2 | cyclin dependent kinase 2 |
| CDKN1A | cyclin dependent kinase inhibitor 1A |
| CMA | chaperone-mediated autophagy |
| CQ | chloroquine |
| CRPC | castration-resistant prostate cancer |
| CTL | cytotoxic T lymphocyte |
| CTNNB1 | catenin beta 1 |
| CYCS | cytochrome c, somatic |
| ΔΨm | mitochondrial membrane potential |
| DAPK | death associated protein kinase 1 |
| DDIT3/CHOP/GADD | DNA damage inducible transcript 3 |
| DMC | demethoxycurcumin |
| EAC | Ehrlich ascites carcinoma |
| EDEM | ER degradation enhancing alpha-mannosidase like protein |
| EHMT2 | euchromatic histone lysine methyltransferase 2 |
| EIF2A/eIF2α | eukaryotic translation initiation factor 2A |
| EIF2AK3/PERK | eukaryotic translation initiation factor 2 alpha kinase 3 |
| ER | endoplasmic reticulum |
| ERN1/IRE1 | endoplasmic reticulum to nucleus signaling 1 |
| FADD | Fas associated via death domain |
| FAS | Fas cell surface death receptor |
| FASLG | Fas ligand |
| FOXO1 | forkhead box O1 |
| GLB1 | galactosidase beta 1 |
| GSK3B | glycogen synthase kinase 3 beta |
| HepG2 | hepatocarcinoma cell line |
| HIF1A/HIF-1α | hypoxia inducible factor 1 subunit alpha |
| HK2 | hexokinase 2 |
| HNSCC | head and neck squamous cell carcinoma |
| HRAS | HRas proto-oncogene, GTPase |
| HSPA5/GRP78/BiP | heat shock protein family A (Hsp70) member 5 |
| HSPA8/HSC70 | heat shock protein family A (Hsp70) member 8 |
| HSP90B1/GRP94 | heat shock protein 90 beta family member 1 |
| IL6 | interleukin 6 |
| KRAS | KRAS proto-oncogene, GTPase |
| LAMP2 | lysosomal associated membrane protein 2 |
| LMS | leiomyosarcoma |
| LV | leucovorin calcium |
| MAP1LC3/LC3 | microtubule associated protein 1 light chain 3 |
| MAPK8/JNK1 | mitogen-activated protein kinase 8/Jun N-terminal kinase |
| MCL1 | MCL1 apoptosis regulator, BCL2 family member |
| MEG3 | maternally expressed 3 |
| MEKi | mitogen-activated protein kinase inhibitor |
| MGMT | O-6-methylguanine-DNA methyltransferase |
| MMP9 | matrix metallopeptidase 9 |
| MTA1 | metastasis associated 1 |
| MT-CO2 | mitochondrially encoded cytochrome c oxidase II |
| MTOR | mechanistic target of rapamycin kinase |
| MTORC1 | MTOR complex 1 |
| MTORC2 | MTOR complex 2 |
| NAC | N-acetyl-L-cysteine |
| NFE2L2/nrf2 | NFE2 like bZIP transcription factor 2 |
| NKT | natural killer T cell |
| NLR | NOD-like receptor |
| NOTCH1 | notch receptor 1 |
| NPC | nasopharyngeal carcinoma |
| NSCLC | non-small cell lung cancer |
| OSCC | oral squamous cell carcinoma |
| p-EGFR | phosphorylated epidermal growth factor receptor |
| PARP | poly(ADP-ribose) polymerase |
| PDE4A | phosphodiesterase 4A |
| PDI | protein disulfide isomerase |
| PDPK1 | 3-phosphoinositide dependent protein kinase 1 |
| PI3K | class I phosphoinositide 3-kinase |
| PIK3C3 | phosphatidylinositol 3-kinase catalytic subunit type 3 |
| PMAIP1/NOXA | phorbol-12-myristate-13-acetate-induced protein 1/(Latin for damage) |
| PPP1R15A/GADD34 | protein phosphatase 1 regulatory subunit 15A |
| PRKCD/PKCδ | protein kinase C delta |
| PtdIns3K | class III phosphatidylinositol 3-kinase |
| PtdIns3P | phosphatidylinositol-3-phosphate |
| PTEN | phosphatase and tensin homolog |
| RECK | reversion inducing cysteine rich protein with kazal motifs |
| RELA | RELA proto-oncogene, NF-kB subunit |
| RELB | RELB proto-oncogene, NF-kB subunit |
| RICTOR | RPTOR independent companion of mTOR complex 2 |
| RNA | ribonucleic acid |
| RNS | reactive nitrogen species |
| ROS | reactive oxygen species |
| RPS6KA1 | ribosomal protein S6 kinase A1 |
| RPS6KB | ribosomal protein S6 kinase B |
| SCC | squamous cell carcinoma |
| SERPINB4 | serpin family B member 4 |
| SH3GLB1/Bif-1 | SH3 domain containing GRB2 like, endophilin B1 |
| siRNA | small-interfering ribonucleic acid |
| SIRT1 | sirtuin 1 |
| SQSTM1/p62 | sequestosome 1 |
| SMPD | sphingomyelin phosphodiesterase |
| STIM1 | stromal interaction molecule 1 |
| STK11 | serine/threonine kinase 11 |
| TAMs | tumor-associated macrophages |
| TFEB | transcription factor EB |
| TGM2 | transglutaminase 2 |
| TLR | toll like receptor |
| TNBC | triple-negative breast cancer |
| TNFRSF10A/TRAIL/Apo2L1 | TNF receptor superfamily member 10a |
| TRAF2 | TNF receptor associated factor 2 |
| Treg | regulatory T cell |
| TSC2 | TSC complex subunit 2 |
| ULK1 | unc-51 like autophagy activating kinase 1 |
| UPR | unfolded protein response |
| UV | ultraviolet |
| UVRAG | UV radiation resistance associated |
| VEGF | vascular endothelial growth factor |
| WIPI1 | WD repeat domain, phosphoinositide interacting 1 |
| WIPI2 | WD repeat domain, phosphoinositide interacting 2 |
| WNT | Wnt family member |
| XBP1 | X-box binding protein 1 |